BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23397397)

  • 1. Flow cytometric measurement of SLAM-associated protein and X-linked inhibitor of apoptosis.
    Marsh RA; Bleesing JJ; Filipovich AH
    Methods Mol Biol; 2013; 979():189-97. PubMed ID: 23397397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency.
    Marsh RA; Bleesing JJ; Filipovich AH
    J Immunol Methods; 2010 Oct; 362(1-2):1-9. PubMed ID: 20816973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical flow cytometric screening of SAP and XIAP expression accurately identifies patients with SH2D1A and XIAP/BIRC4 mutations.
    Gifford CE; Weingartner E; Villanueva J; Johnson J; Zhang K; Filipovich AH; Bleesing JJ; Marsh RA
    Cytometry B Clin Cytom; 2014 Jul; 86(4):263-71. PubMed ID: 24616127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
    Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
    Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency.
    Marsh RA; Villanueva J; Zhang K; Snow AL; Su HC; Madden L; Mody R; Kitchen B; Marmer D; Jordan MB; Risma KA; Filipovich AH; Bleesing JJ
    Cytometry B Clin Cytom; 2009 Sep; 76(5):334-44. PubMed ID: 19288545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis.
    Yang X; Miyawaki T; Kanegane H
    Pediatr Int; 2012 Aug; 54(4):447-54. PubMed ID: 22672194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP).
    Rumble JM; Oetjen KA; Stein PL; Schwartzberg PL; Moore BB; Duckett CS
    Cell Immunol; 2009; 259(1):82-9. PubMed ID: 19595300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutations in SH2D1A identified in patients with X-linked lymphoproliferative disease differentially affect the expression and function of SAP.
    Hare NJ; Ma CS; Alvaro F; Nichols KE; Tangye SG
    Int Immunol; 2006 Jul; 18(7):1055-65. PubMed ID: 16720617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer T cells and X-linked lymphoproliferative syndrome.
    Latour S
    Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):510-4. PubMed ID: 17989527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
    Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
    Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
    Veillette A; Pérez-Quintero LA; Latour S
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes.
    Veillette A; Dong Z; Latour S
    Immunity; 2007 Nov; 27(5):698-710. PubMed ID: 18031694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.
    Rezaei N; Mahmoudi E; Aghamohammadi A; Das R; Nichols KE
    Br J Haematol; 2011 Jan; 152(1):13-30. PubMed ID: 21083659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53 activates SAP expression in lymphoid cells.
    Nagy N; Takahara M; Nishikawa J; Bourdon JC; Kis LL; Klein G; Klein E
    Oncogene; 2004 Nov; 23(53):8563-70. PubMed ID: 15378026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
    Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
    J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product.
    Latour S; Gish G; Helgason CD; Humphries RK; Pawson T; Veillette A
    Nat Immunol; 2001 Aug; 2(8):681-90. PubMed ID: 11477403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines.
    Nagy N; Cerboni C; Mattsson K; Maeda A; Gogolák P; Sümegi J; Lányi A; Székely L; Carbone E; Klein G; Klein E
    Int J Cancer; 2000 Nov; 88(3):439-47. PubMed ID: 11054674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked lymphoproliferative disease: a progressive immunodeficiency.
    Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
    Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.